Gene Therapy: Helping To Bring New Innovations To Light With Gene-ious Moments

Nearly half a century after scientists first proposed the revolutionary idea of modifying patients’ genes to cure illness, we find ourselves at the precipice of change. With 11 approvals and over 30 programs in late-stage development industry wide, the spotlight is on developers and manufacturers to unlock the potential of gene therapies.

When gene therapies are progressed through the various stages of clinical phases and launch, key decision-making factors critical for success center around process development as well as chemistry, manufacturing and controls (CMC). Although some of these factors can be optimized in late-stage processes, the need to maintain regulatory and clinical consistency means many decisions must be conserved from early stages.

In this webinar, global Pfizer gene therapy scientists & manufacturing experts will share their unique insights exploring how to help overcome development, scale-up, analytical and manufacturing challenges.